BRAIN Biotech AG (BNN) - Total Liabilities

Latest as of September 2025: €64.50 Million EUR ≈ $75.40 Million USD

Based on the latest financial reports, BRAIN Biotech AG (BNN) has total liabilities worth €64.50 Million EUR (≈ $75.40 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

BRAIN Biotech AG - Total Liabilities Trend (2012–2025)

This chart illustrates how BRAIN Biotech AG's total liabilities have evolved over time, based on quarterly financial data. See BRAIN Biotech AG (BNN) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

BRAIN Biotech AG Competitors by Total Liabilities

The table below lists competitors of BRAIN Biotech AG ranked by their total liabilities.

Company	Country	Total Liabilities
Allegiant Gold Ltd V:AUAU	Canada	CA$695.03K
Linz Textil Holding AG VI:LTH	Austria	€12.40 Million
Shenzhen SEG Co Ltd SHE:200058	China	HK$2.47 Billion
Futuretech II Acquisition Corp NASDAQ:FTII	USA	$10.38 Million
Hofseth Biocare ASA OL:HBC	Norway	Nkr419.19 Million
Waskita Beton Precast Tbk PT JK:WSBP	Indonesia	Rp5.05 Trillion
ICE FISH FARM AS NK-10 F:4YYA	Germany	€230.30 Million
Helixmith Co. Ltd KQ:084990	Korea	₩1.66 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down BRAIN Biotech AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BNN market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.35	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	35.03	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.97	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BRAIN Biotech AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BRAIN Biotech AG (2012–2025)

The table below shows the annual total liabilities of BRAIN Biotech AG from 2012 to 2025.

Year	Total Liabilities	Change
2025-09-30	€64.50 Million ≈ $75.40 Million	-13.83%
2024-09-30	€74.85 Million ≈ $87.51 Million	+56.19%
2023-09-30	€47.92 Million ≈ $56.03 Million	+9.55%
2022-09-30	€43.74 Million ≈ $51.14 Million	+21.82%
2021-09-30	€35.91 Million ≈ $41.98 Million	-21.95%
2020-09-30	€46.01 Million ≈ $53.79 Million	-6.17%
2019-09-30	€49.03 Million ≈ $57.32 Million	+11.88%
2018-09-30	€43.83 Million ≈ $51.24 Million	+107.29%
2017-09-30	€21.14 Million ≈ $24.72 Million	+2.70%
2016-09-30	€20.59 Million ≈ $24.07 Million	-16.49%
2015-09-30	€24.65 Million ≈ $28.82 Million	+119.64%
2014-09-30	€11.22 Million ≈ $13.12 Million	+49.55%
2013-09-30	€7.51 Million ≈ $8.77 Million	-1.08%
2012-09-30	€7.59 Million ≈ $8.87 Million	--

About BRAIN Biotech AG

XETRA:BNN Germany Specialty Chemicals

Market Cap

$73.05 Million

€62.48 Million EUR

Market Cap Rank

#21856 Global

#1947 in Germany

Share Price

€2.86

Change (1 day)

+0.70%

52-Week Range

€1.85 - €3.66

All Time High

€27.50